Direct targeting of human cytomegalovirus protein kinase pUL97 by kinase inhibitors is a novel principle for antiviral therapy

Journal of General Virology

Volumn 83, Issue 5, 2002, Pages 1013-1023

  Marschall, Manfred ^a   Stein Gerlach, Matthias ^a   Freitag, Martina ^a   Kupfer, Rigina ^a   van den Bogaard, Miriam ^a   Stamminger, Thomas ^a  

^a UNIVERSITY HOSPITAL ERLANGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

12 (2 CYANOETHYL) 6,7,12,13 TETRAHYDRO 13 METHYL 5 OXOINDOLO[2,3 A]PYRROLO[3,4 C]CARBAZOLE; CARBAZOLE DERIVATIVE; CIDOFOVIR; GANCICLOVIR; GO 7874; GREEN FLUORESCENT PROTEIN; NGIC 1; PROTEIN KINASE; PROTEIN KINASE INHIBITOR; PROTEIN UL 97; STAUROSPORINE; UNCLASSIFIED DRUG; VIRUS ENZYME;

ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; AUTOPHOSPHORYLATION; CONTROLLED STUDY; DELETION MUTANT; DRUG INHIBITION; DRUG RESISTANCE; DRUG SENSITIVITY; DRUG STRUCTURE; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; EPSTEIN BARR VIRUS; GENE FUNCTION; GENETIC CODE; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN CYTOMEGALOVIRUS; MOLECULAR CLONING; NONHUMAN; OPEN READING FRAME; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TARGETING; QUANTITATIVE ASSAY; SEQUENCE HOMOLOGY; VIRUS INHIBITION; VIRUS MUTANT; VIRUS RECOMBINANT; VIRUS REPLICATION; WILD TYPE;

ANIMALIA; CYTOMEGALOVIRUS; DNA VIRUSES; HUMAN HERPESVIRUS 4; HUMAN HERPESVIRUS 5;

EID: 0036255961     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/0022-1317-83-5-1013     Document Type: Article

References (45)

1. The human cytomegalovirus genes required for DNA synthesis
2. Human cytomegalovirus clinical isolates carry at least 19 genes not found in laboratory strains
3. Alpha-, beta- and gammaherpesviruses encode a putative phophotransferase
4. A protein kinase associated with Epstein-Barr virus BGLF4 phosphorylates the viral early antigen EA-D in vitro
5. Development of novel benzimidazole riboside compounds for treatment of cytomegalovirus disease
6. Antiviral therapy
7. Valganciclovir
8. Mapping of a mutation in human cytomegalovirus resistant to 1263W94
9. Antiviral activity of artesunate towards wild-type, recombinant and ganciclovir-resistant human cytomegalovirus
10. Prediction of cytomegalovirus load and resistance patterns after antiviral chemotherapy
11. Resistance of human cytomegalovirus to antiviral drugs
12. Protein kinase C in treatment of diseases: Signal transduction pathways, inhibitors and agents in development
13. The Epstein-Barr virus thymidine kinase does not phosphorylate ganciclovir or acyclovir and demonstrates a narrow substrate specificity compared to the herpes simplex virus type 1 thymidine kinase
14. The human cytomegalovirus UL97 protein is a protein kinase that autophosphorylates on serines and threonines
15. Mutations conferring ganciclovir resistance in a cohort of patients with acquired immunodeficiency syndrome and cytomegalovirus retinitis
16. Cellular elongation factor 1δ is modified in cells infected with representative alpha-, beta-, or gammaherpesviruses
17. Non-glycosidic/non-aminoalkyl-substituted indolocarbazoles as inhibitors of protein kinase C
18. Rapid and efficient site-specific mutagenesis without phenotypic selection
19. Emergence of ganciclovir-resistant cytomegalovirus disease among recipients of solid-organ transplants
20. Human cytomegalovirus UL97 open reading frame encodes a protein that phosphorylates the antiviral nucleoside analogue ganciclovir
21. Prevalence of antiviral drug resistance in untreated patients with cytomegalovirus retinitis
22. Valacyclovir for the prevention of cytomegalovirus disease after renal transplantation
23. Inhibition of ganciclovir-susceptible and -resistant human cytomegalovirus clinical isolates by the benzimidazole L-riboside 1263W94
24. Recombinant green fluorescent protein-expressing human cytomegalovirus as a tool for screening antiviral agents
25. Inhibitors of human cytomegalovirus replication drastically reduce the activity of the viral protein kinase pUL97
26. Inhibition of the pUL97 protein kinase is an antiviral strategy to interfere with the replication of human cytomegalovirus
27. The UL97 gene product of human cytomegalovirus is an early-late protein with nuclear localization but is not a nucleoside kinase
28. Functional regions of the human cytomegalovirus protein pUL97 involved in nuclear localization and phosphorylation of ganciclovir and pUL97 itself
29. Amino acids of conserved kinase motifs of cytomegalovirus protein UL97 are essential for autophosphorylation
30. Partial substitution of the functions of the herpes simplex virus 1 UL13 gene by the human cytomegalovirus UL97 gene
31. Cytomegaloviruses
32. Fomivirsen
33. Advances in indolo(2,3-a)carbazole chemistry: Design and synthesis of protein kinase C and topoisomerase I inhibitors
34. A recombinant human cytomegalovirus with a large deletion in UL97 has a severe replication deficiency
35. A review of genetic differences between limited and extensively passaged human cytomegalovirus strains
36. Simple algorithm derived from a geno-/phenotypic database to predict HIV-1 protease inhibitor resistance
37. Inhibition of cytomegalovirus immediate early gene expression: A therapeutic option?
38. Indolocarbazoles: Potent, selective inhibitors of human cytomegalovirus replication
39. A protein kinase homologue controls phosphorylation of ganciclovir in human cytomegalovirus-infected cells
40. Acyclovir is phosphorylated by the human cytomegalovirus UL97 protein
41. Distinct and separate roles for herpesvirus-conserved UL97 kinase in cytomegalovirus DNA synthesis and encapsidation
42. Site-directed mutation in a conserved kinase domain of human cytomegalovirus-pp65 with preservation of cytotoxic T lymphocyte targeting
43. Inhibition of Epstein-Barr virus replication by a benzimidazole L-riboside: Novel antiviral mechanism of 5,6-dichloro-2-(isopropylamino)-1-β-L-ribofuranosyl-1H-benzimidazole
44. Indolocarbazoles exhibit strong antiviral activity against human cytomegalovirus and are potent inhibitors of the pUL97 protein kinase